Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study

INTRODUCTION: Ischaemic heart disease (IHD) is one of the most common causes of death in the UK and treatment of patients with IHD costs the National Health System (NHS) billions of pounds each year. Allopurinol is a xanthine oxidase inhibitor used to prevent gout that also has several positive effe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Mackenzie, Isla S, Ford, Ian, Walker, Andrew, Hawkey, Chris, Begg, Alan, Avery, Anthony, Taggar, Jaspal, Wei, Li, Struthers, Allan D, MacDonald, Thomas M
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Cardiovascular Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5020706/
https://ncbi.nlm.nih.gov/pubmed/27609859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-013774
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados